ODONATE THERAPEUTICS INC's ticker is ODT and the CUSIP is 676079106. A total of 92 filers reported holding ODONATE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.34 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $31,000 | -82.3% | 9,149 | +0.3% | 0.00% | -100.0% |
| Q4 2020 | $175,000 | +66.7% | 9,124 | +16.7% | 0.00% | 0.0% |
| Q3 2020 | $105,000 | -69.0% | 7,819 | -2.2% | 0.00% | -50.0% |
| Q2 2020 | $339,000 | +115.9% | 7,997 | +40.5% | 0.00% | +100.0% |
| Q1 2020 | $157,000 | -34.0% | 5,692 | -22.5% | 0.00% | 0.0% |
| Q4 2019 | $238,000 | +23.3% | 7,343 | -0.8% | 0.00% | 0.0% |
| Q3 2019 | $193,000 | +6.6% | 7,404 | +50.1% | 0.00% | 0.0% |
| Q2 2019 | $181,000 | +88.5% | 4,932 | +14.0% | 0.00% | – |
| Q1 2019 | $96,000 | +52.4% | 4,325 | -3.1% | 0.00% | – |
| Q4 2018 | $63,000 | -27.6% | 4,465 | -0.8% | 0.00% | – |
| Q3 2018 | $87,000 | -11.2% | 4,500 | +1.8% | 0.00% | – |
| Q2 2018 | $98,000 | +6.5% | 4,419 | +2.3% | 0.00% | – |
| Q1 2018 | $92,000 | – | 4,321 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 15,514,566 | $297,880,000 | 45.48% |
| Boxer Capital, LLC | 5,607,086 | $107,656,000 | 3.46% |
| Samsara BioCapital, LLC | 815,421 | $15,656,000 | 1.57% |
| GSA CAPITAL PARTNERS LLP | 148,148 | $2,844,000 | 0.46% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,211,728 | $23,265,000 | 0.38% |
| RTW INVESTMENTS, LP | 1,000,139 | $19,203,000 | 0.32% |
| Sio Capital Management, LLC | 75,500 | $1,450,000 | 0.30% |
| AlphaCentric Advisors LLC | 29,594 | $568,000 | 0.24% |
| Birchview Capital, LP | 20,000 | $384,000 | 0.22% |
| Aristides Capital LLC | 33,226 | $638,000 | 0.22% |